Ondine Biomedical Inc.
OBIMF
$0.14
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -62.49% | -44.89% | -30.31% | 0.03% | 24.64% |
| Total Depreciation and Amortization | 1.34% | -2.88% | -5.15% | -2.23% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 245.64% | 177.93% | 135.84% | 15.79% | -58.34% |
| Change in Net Operating Assets | 322.69% | 933.69% | 722.62% | 784.75% | 1,118.38% |
| Cash from Operations | -43.51% | -25.62% | -11.66% | 6.56% | 22.99% |
| Capital Expenditure | -78.13% | 82.89% | 94.36% | 94.17% | 94.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -78.13% | 82.89% | 94.36% | 94.17% | 94.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -117.73% | -121.68% | -125.76% | -86.70% | -35.38% |
| Issuance of Common Stock | 106.84% | 187.55% | 367.83% | 591.18% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.24% | -70.97% | -175.86% | -354.43% | -- |
| Cash from Financing | 131.17% | 225.76% | 463.90% | 782.26% | 2,927.95% |
| Foreign Exchange rate Adjustments | 908.90% | 12,720.51% | 705.15% | 166.05% | -76.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 230.58% | 181.21% | 165.08% | 113.29% | 80.54% |